Oncotarget

Research Papers:

The value of systemic inflammatory markers in identifying malignancy in mucinous pancreatic cystic neoplasms

Wentao Zhou, Yefei Rong, Tiantao Kuang, Yadong Xu, Xiaojing Shen, Yuan Ji, Wenhui Lou and Dansong Wang _

PDF  |  HTML  |  Supplementary Files  |  How to cite  |  Order a Reprint

Oncotarget. 2017; 8:115561-115569. https://doi.org/10.18632/oncotarget.23310

Metrics: PDF 330 views  |   HTML 836 views  |   ?  


Abstract

Wentao Zhou1,*, Yefei Rong1,*, Tiantao Kuang1,*, Yadong Xu2, Xiaojing Shen3, Yuan Ji3, Wenhui Lou2 and Dansong Wang1

1Department of General Surgery, Zhong Shan Hospital, Fudan University, Shanghai, China

2Department of Pancreatic Surgery, Zhong Shan Hospital, Fudan University, Shanghai, China

3Department of Pathology, Zhong Shan Hospital, Fudan University, Shanghai, China

*These authors have contributed equally to this work

Correspondence to:

Dansong Wang, email: wang.dansong@outlook.com

Keywords: systemic inflammatory markers; pancreatic cystic neoplasm; invasive carcinoma; platelet-to-lymphocyte ratio; lymphocyte-to-monocyte ratio

Received: August 23, 2017     Accepted: December 04, 2017     Published: December 14, 2017

ABSTRACT

The treatment decision-making of mucinous pancreatic cystic neoplasm (PCN) has become a common clinical problem since the diagnostic accuracy of current tests in identifying malignancies in pancreatic cysts is limited. In this study, we aimed to validate the predictive value of systemic inflammatory factors in detecting malignant PCNs. Two hundred and forty-five patients with pathologically confirmed mucinous PCNs in a single Chinese institution were retrospectively analyzed. Receiver operating characteristic (ROC) curves were calculated to determine the optimal cut-off values and measure the diagnostic value. The results showed that neutrophil count (P = 0.009), lymphocyte count (P = 0.002), neutrophil-to-lymphocyte ratio (NLR, P < 0.001), platelet-to-lymphocyte ratio (PLR, P < 0.001) and lymphocyte-to-monocyte ratio (LMR, P < 0.001) were distributed differently among the various differentiation groups of PCN. The univariate analyses indicated that a neutrophil count ≥ 2.8 × 109/L (P = 0.024), lymphocyte count ≤ 1.9 × 109/L (P < 0.001), PLR ≥ 125 (P < 0.001), NLR ≥ 1.96 (P < 0.001), and LMR ≤ 4.29 (P < 0.001) were significantly associated with invasive carcinomas in PCN patients. In addition, the multivariate analyses demonstrated that PLR ≥ 125 and LMR ≤ 4.29 were independent predictors of invasive malignancies. The ROC curves exhibited the malignant detection utility of the independent factor-based predictive model with an area under the curve (AUC) of 0.858 (P < 0.001). In conclusion, systemic inflammatory markers provide a supportive and easily accessible tool for the preoperative diagnoses of malignant PCNs.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 23310